332 related articles for article (PubMed ID: 2116665)
1. Two G protein oncogenes in human endocrine tumors.
Lyons J; Landis CA; Harsh G; Vallar L; Grünewald K; Feichtinger H; Duh QY; Clark OH; Kawasaki E; Bourne HR
Science; 1990 Aug; 249(4969):655-9. PubMed ID: 2116665
[TBL] [Abstract][Full Text] [Related]
2. GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.
Vallar L
Biochem Soc Symp; 1990; 56():165-70. PubMed ID: 2124121
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
4. Activating point mutations of the gsp oncogene in human thyroid adenomas.
O'Sullivan C; Barton CM; Staddon SL; Brown CL; Lemoine NR
Mol Carcinog; 1991; 4(5):345-9. PubMed ID: 1910478
[TBL] [Abstract][Full Text] [Related]
5. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
[TBL] [Abstract][Full Text] [Related]
6. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
7. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
Landis CA; Masters SB; Spada A; Pace AM; Bourne HR; Vallar L
Nature; 1989 Aug; 340(6236):692-6. PubMed ID: 2549426
[TBL] [Abstract][Full Text] [Related]
8. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.
Drews RT; Gravel RA; Collu R
Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784
[TBL] [Abstract][Full Text] [Related]
9. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E
J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
[TBL] [Abstract][Full Text] [Related]
10. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
11. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
[TBL] [Abstract][Full Text] [Related]
12. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms.
Reincke M; Karl M; Travis W; Chrousos GP
J Clin Endocrinol Metab; 1993 Nov; 77(5):1419-22. PubMed ID: 8077343
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas: screening for G alpha q mutations.
Oyesiku NM; Evans CO; Brown MR; Blevins LS; Tindall GT; Parks JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):4184-8. PubMed ID: 9398737
[TBL] [Abstract][Full Text] [Related]
14. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.
Williamson EA; Daniels M; Foster S; Kelly WF; Kendall-Taylor P; Harris PE
Clin Endocrinol (Oxf); 1994 Dec; 41(6):815-20. PubMed ID: 7889619
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.
Gicquel C; Dib A; Bertagna X; Amselem S; Le Bouc Y
Eur J Endocrinol; 1995 Aug; 133(2):166-72. PubMed ID: 7655640
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
17. Absence of mutations in the Gs alpha and Gi2 alpha genes in sporadic parathyroid adenomas and insulinomas.
Vessey SJ; Jones PM; Wallis SC; Schofield J; Bloom SR
Clin Sci (Lond); 1994 Nov; 87(5):493-7. PubMed ID: 7874835
[TBL] [Abstract][Full Text] [Related]
18. G protein gene mutations in patients with multiple endocrinopathies.
Williamson EA; Johnson SJ; Foster S; Kendall-Taylor P; Harris PE
J Clin Endocrinol Metab; 1995 May; 80(5):1702-5. PubMed ID: 7745022
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of heterotrimeric G proteins.
Vallar L
Cancer Surv; 1996; 27():325-38. PubMed ID: 8909808
[TBL] [Abstract][Full Text] [Related]
20. Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation.
Wong YH; Federman A; Pace AM; Zachary I; Evans T; Pouysségur J; Bourne HR
Nature; 1991 May; 351(6321):63-5. PubMed ID: 1851251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
